2-(2-(4-(2-chlorophenyl)-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)ethyl)-5-p-tolyl-1,3,4-oxadiazole

ID: ALA2325499

PubChem CID: 49833459

Max Phase: Preclinical

Molecular Formula: C24H19ClN6O

Molecular Weight: 442.91

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(-c2nnc(CCc3nnc(-c4ccncc4)n3-c3ccccc3Cl)o2)cc1

Standard InChI:  InChI=1S/C24H19ClN6O/c1-16-6-8-18(9-7-16)24-30-28-22(32-24)11-10-21-27-29-23(17-12-14-26-15-13-17)31(21)20-5-3-2-4-19(20)25/h2-9,12-15H,10-11H2,1H3

Standard InChI Key:  BSGNOJZPCZALIF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
   18.6908  -11.6057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6897  -12.4253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3977  -12.8342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1074  -12.4248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1045  -11.6021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3959  -11.1969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3961  -13.6504    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.7349  -14.1306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9873  -14.9078    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.8045  -14.9080    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.0571  -14.1309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8313  -13.8778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4384  -14.4264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2150  -14.1746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3857  -13.3745    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.7736  -12.8267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9993  -13.0815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9578  -13.8779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3504  -14.4245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5733  -14.1718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3214  -13.3925    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5042  -13.3923    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.2515  -14.1695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9126  -14.6499    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.4736  -14.4248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8665  -13.8762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0933  -14.1280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9255  -14.9281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5313  -15.4759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3056  -15.2211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9816  -12.8333    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   12.1507  -15.1812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  7  1  0
  3  7  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 11 12  1  0
  8 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 20  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 23 25  1  0
  2 31  1  0
 28 32  1  0
M  END

Associated Targets(Human)

TNKS2 Tchem Tankyrase 1/2 (384 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (16955 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TNKS2 Tchem Tankyrase-2 (1531 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 442.91Molecular Weight (Monoisotopic): 442.1309AlogP: 5.13#Rotatable Bonds: 6
Polar Surface Area: 82.52Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 3.77CX LogP: 3.97CX LogD: 3.97
Aromatic Rings: 5Heavy Atoms: 32QED Weighted: 0.36Np Likeness Score: -1.91

References

1. Voronkov A, Holsworth DD, Waaler J, Wilson SR, Ekblad B, Perdreau-Dahl H, Dinh H, Drewes G, Hopf C, Morth JP, Krauss S..  (2013)  Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor.,  56  (7): [PMID:23473363] [10.1021/jm4000566]

Source